{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","spread":"15.99","value":"133.7"},{"groupId":"OG001","spread":"19.00","value":"133.6"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"268"},{"groupId":"OG001","value":"117"}],"units":"Participants"}],"title":"Systolic Blood Pressure: Baseline (Actual)"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"16.57","value":"133.7"},{"groupId":"OG001","spread":"19.11","value":"132.1"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"265"},{"groupId":"OG001","value":"114"}],"units":"Participants"}],"title":"Systolic Blood Pressure: Post-dosing (Actual)"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"12.30","value":"0.1"},{"groupId":"OG001","spread":"11.57","value":"-1.3"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"265"},{"groupId":"OG001","value":"114"}],"units":"Participants"}],"title":"Systolic Blood Pressure: Change from Baseline"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"8.62","value":"79.3"},{"groupId":"OG001","spread":"10.16","value":"77.2"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"268"},{"groupId":"OG001","value":"117"}],"units":"Participants"}],"title":"Diastolic Blood Pressure: Baseline (Actual)"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"9.12","value":"78.5"},{"groupId":"OG001","spread":"9.02","value":"76.4"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"265"},{"groupId":"OG001","value":"114"}],"units":"Participants"}],"title":"Diastolic Blood Pressure: Post-dosing (Actual)"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"7.04","value":"-0.7"},{"groupId":"OG001","spread":"8.18","value":"-0.7"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"265"},{"groupId":"OG001","value":"114"}],"units":"Participants"}],"title":"Diastolic Blood Pressure: Change from Baseline"}],"denoms":[{"counts":[{"groupId":"OG000","value":"268"},{"groupId":"OG001","value":"117"}],"units":"Participants"}],"dispersionType":"Standard Deviation","groups":[{"description":"High risk prostate cancer participants planned for radical prostatectomy with pelvic lymph node dissection (Cohort A) were enrolled to receive a single dose of 9 mCi (333 MBq) IV injection of 18F-DCFPyL, followed by PET/CT imaging acquired 1-2 hours post-PyL injection.","id":"OG000","title":"High Risk Prostate Cancer (Cohort A)"},{"description":"Participants with presumptive radiologic evidence of prostate cancer recurrence or metastasis on conventional imaging and planned for conventional image-guided biopsy (Cohort B) were enrolled to receive a single dose of 9 mCi (333 MBq) IV injection of 18F-DCFPyL, followed by PET/CT imaging acquired 1-2 hours post-PyL injection.","id":"OG001","title":"Recurrent or Metastatic Prostate Cancer (Cohort B)"}],"paramType":"MEAN","populationDescription":"The Safety Set includes all participants who received any amount of 18F-DCFPyL and have reported data (i.e., some participants had missing vital sign measurements).","reportingStatus":"POSTED","timeFrame":"Measured at two intervals on the day of dosing, pre-dosing (baseline) and post-dosing/pre-imaging.","title":"Mean Changes From Baseline in Blood Pressure Post 18F-DCFPyL Dosing (Safety Outcome Measure)","type":"SECONDARY","unitOfMeasure":"mm Hg"}